Previous close | 2.7000 |
Open | 2.5500 |
Bid | 0.0000 |
Ask | 0.0000 |
Strike | 45.00 |
Expiry date | 2024-07-19 |
Day's range | 2.5000 - 2.7000 |
Contract range | N/A |
Volume | |
Open interest | N/A |
Oppenheimer & Co. Inc. (Oppenheimer) — a leading investment bank, wealth manager and a subsidiary of Oppenheimer Holdings (NYSE: OPY) — announced today that Kunal Bhatia joined as a Managing Director in the firm's Healthcare Investment Banking Group. He will be based in New York and report to Michael Margolis, R.Ph, Oppenheimer's Co-Head of Healthcare and Head of Healthcare Life Sciences Investment Banking.
Key Insights Insiders appear to have a vested interest in Oppenheimer Holdings' growth, as seen by their sizeable...
Oppenheimer Europe (Oppenheimer) — a subsidiary of Oppenheimer Holdings, the leading investment bank and wealth manager (NYSE: OPY) — announced today a further expansion of its European investment banking footprint with the addition of Martin Chamberlin.